ࡱ> DFC%` 0bjbj"x"x .8@@T8888888Lppp84,L"(<RRRRh t$h8RR88RRIIId8R8RIII88IR yHp|I}$0"I*^*I*8I4|FItJi|||X|||"LLL$ pLLLpLLL888888 Institute of Sport and Physical Activity Research Participant Information Sheet STUDY TITLE Principal YOUR NAME, ý Investigators: YOUR SUPERVISORS NAME, ý Project date: Sept 2012 January 2013 Email: your study beds email; your supervisors email Telephone: your supervisors UNIVERSITY contact telephone NOTES: Please place the ethical approval number at the top of this letter and at the top of consent forms, with a copy of the ý logo. These are MANDATORY on all forms distributed to participants. To help you complete this section, please refer to the Participant Information Sheet Guidance below. You MUST keep wording in the red, develop points in black, remembering that you need SEPARATE forms for participants of different ages e.g. an information letter will use different language if it is aimed at an 8 year old child, than for a fully fledge adult. Having said that, the average reading age of an adult is about 12-13 years old, so you need to make sure you write at the appropriate level for your target group, avoiding references to complicated techniques, protocols and instruments, and putting this information in a way they can easy understand. You can check readability statistics in Word to check you are on the right linesHYPERLINK "http://office.microsoft.com/en-us/word-help/test-your-document-s-readability-HP010148506.aspx" \l "BM13"http://office.microsoft.com/en-us/word-help/test-your-document-s-readability-HP010148506.aspx - BM13) 1. ý title Is the title self-explanatory? If not, a simplified title should be included. 2. Invitation paragraph This should explain that the patient is being asked to take part in a research study. The following is a suitable example: You are being invited to take part in a research study. Before you decide it is important for you to understand why the research is being done and what it will involve. Please take time to read the following information carefully and discuss it with others if you wish. Ask us if there is anything that is not clear or if you would like more information. Take time to decide whether or not you wish to take part. Thank you for reading this. 3. What is the purpose of the study? The background and aim of the study should be given here. Also mention the duration of the study. 4. Why have I been chosen? You should explain how the participant was chosen and how many other patients will be involved in the study. 5. Do I have to take part? You should explain that taking part in the research is entirely voluntary. You could use the following paragraph:- It is up to you to decide whether or not to take part. If you do decide to take part you will be given this information sheet to keep and be asked to sign a consent/ascent form. If you decide to take part you are still free to withdraw at any time and without giving a reason. A decision to withdraw at any time, or a decision not to take part, will not affect the standard of care you receive. 6. What will happen to me if I take part? You should say how long the participant will be involved in the research, how long the research will last (if this is different), how often they will need to take part (if this is appropriate) and how long these interactions will be. Whenever possible you should draw a simple flowchart or plan indicating what will happen at each visit (if this is appropriate). What are the participants responsibilities? Set down clearly what you expect of them. 7. What are the possible benefits of taking part? It is important not to exaggerate the possible benefits to the particular participant during the course of the study. 8. Will my taking part in this study be kept confidential? You will need to obtain the participants permission to allow restricted access to their records and to the information collected about them in the course of the study. You should explain that all information collected about them will be kept strictly confidential. You should also convey how the data will be stored during the life cycle of the project in order to protect participants personal details? How is data being destroyed in order to protect participants personal details? All information which is collected about you during the course of the research will be kept strictly confidential. Any information about you will have your name and address removed so that you cannot be recognised from it. You should always bear in mind that you, as the researcher, are responsible for ensuring that when collecting or using data, you are not contravening the legal or regulatory requirements in any part of the UK. 9 What will happen to the results of the research study? You should be able to tell the participants what will happen to the results of the research. When are the results likely to be published? Where can they obtain a copy of the published results? You might add that they will not be identified in any report/publication. 10 Contacts for Further Information You should give the participant a contact point for further information (i.e. your UNIVERSITY email and your Supervisors UNIVERSITY EMAIL and UNIVERSITY TELEPHONE number. DO NOT UNDER ANY CIRMCUMSTANCES PUT PERSONAL EMAILS OR TELEPHONE NUMBERS ON THIS FORM. You also MUST provide an independent contact: Alternatively, if you would like to speak with someone independent from the research study please contact:Professor Angus Duncan: Secretary to the ý Research Ethics Committee, Email: HYPERLINK "mailto:angus.duncan@beds.ac.uk"angus.duncan@beds.ac.uk, Telephone: 01582 743473. Thank you for taking your time to read this information letter! Please keep this form for your records.     ETHICAL APPROVAL NUMBER:  HYPERLINK "http://www.beds.ac.uk/"  23RS^`yó~k\P\kk~k\P\PAhaYhfCJOJQJ^JhfCJOJQJ^JhnIhfCJOJQJ^J$hnIhfCJOJQJ^JmH sH hfCJOJQJ^JmH sH *hnIhf56CJOJQJ^JmH sH hf5CJOJQJ\^Jhf5B*OJQJ^Jphhf5@OJQJaJ#hUhf5@CJOJQJaJhUhf5CJOJQJaJhf5CJOJQJaJ34RS_`  G H zzz' 2`Y) i9 !y$0^0`gdf' 2IY) i9 !y$0^0`gdf^gdf $^a$gdf$]^a$gdf d*$gdfgdf     . / G H S U ӲӣxfT=T,h:bWhf6B*CJOJQJ^JaJph#h:bWhf6CJOJQJ^JaJ#hfB*CJOJQJ^JaJph&hf6B*CJOJQJ^JaJph,h:bWhf6B*CJOJQJ^JaJphhf5CJOJQJ\^J"haYhf56CJOJQJ^JhaYhfCJOJQJ^JhfCJOJQJ^JhnIhfCJOJQJ^J"hnIhf56CJOJQJ^J T U .}~[\w@&gdf# 2`Y) i9 !y$0^0gdfgdf B C "-.@UV~辧i[Mi8)hf6B*CJOJQJ]^JaJphhiuCJOJQJ^JaJhfCJOJQJ^JaJ/hshf5B*CJOJQJ\^JaJph)hshfB*CJOJQJ^JaJph h:bWhfCJOJQJ^JaJ,h:bWhf6B*CJOJQJ^JaJph#h:bWhf6CJOJQJ^JaJ'hYhf0J6CJOJQJ^JaJhfjhfUhf6CJOJQJ^JaJ\_vwtu-.%&翪wkW&h:bWhf6CJOJQJ]^JaJh:bWhf6CJaJh:bWhfB*CJaJphhfB*CJaJph/hshf5B*CJOJQJ\^JaJph)hshfB*CJOJQJ^JaJph h:bWhfCJOJQJ^JaJ,h:bWhf6B*CJOJQJ^JaJph/h:bWhf6B*CJOJQJ]^JaJph!tu.&{|=@&gdiu@&gdf$a$gdfdgdfgdf{|~  !"<=>}ëë؝}y}_}P8/h:bWhf56B*CJOJQJ^JaJphh:bWhfCJOJQJaJ3h:bWhf0J6B*CJOJQJ\^JaJphhfjhfU/h:bWhf6B*CJOJQJ\^JaJphhfCJOJQJ^JaJ/hshf5B*CJOJQJ\^JaJph)hshfB*CJOJQJ^JaJph h:bWhfCJOJQJ^JaJ,h:bWhfB*CJOJQJ]^JaJph=>~ $$Ifa$gd $Ifgd$]^a$gdf X 8"d*$gdf}~viehhUhfOJQJ^J7jh\hf5CJOJQJU_HEaJmHnHuhfjhfU#h\hf5CJOJQJ^JaJh 7jh 7Uh/ h:bWhf6B*CJaJph/h:bWhf56B*CJOJQJ^JaJph,h:bWhf6B*CJOJQJ^JaJphgdfTkd` $$Ifl0 ZZ t644 layt,1h. A!"#$% ` Dd ? ::  A?P Picture 2Description: University of Bedfordshire"bF Y5ZB_S@" Dn Y5ZB_S@PNG  IHDRvaPLTE*瀔234̘efg?@A²7YYZrstLMM乺2Razqꐡ"E㳴A_Qmͧ3}bKGDH cmPPJCmp0712HsIDATx^훉v: M {5Nf2KfiϜtII,F۬RwW)1{zگ7Dqʈ*6t  э U-R]?Rȹ~k_Do$ڍdo_9a#$Y$rn} +,OUk_e~]| c9h@=@1?[ZeD{ݳ#Dg=}DԺU]nوִ.~Fwx/ב@mTZKw G5n*8 ׹ȐLeP8]޹TOвsǼDN ILjQlFZ~@5im2W83n6.cЛ1ب2ֳ  WQ{4iF:3YG&Iy\|kopOsFL)"Vvt4z)]M3l'瞧b ܘL0"Y3Eù;C%!_>ʴլMʋՃDx\qT{b#G.|jlk"X mh'z* 4QψS3 Zm(5L ATN)RPR(Ec"l"kzoVD:#׉ i"Ga]ֈ2&9fd/~UJ4nk><Pq76(OpKޑs vutY[ ^?,˧W4ͰPȡ S,h8ĢNx"24L3_m+@%~N_=dsXI@yH/_A|O R/8KtRwBK^z {)R}5}V?=Oh|W׿rC=reo{ 2ǷN ԋ@W> B!x|U)ZdJbp B Ro2km0 aOA,D7 s-X@] vK2}_)@O. 6ڽ,$/9أ|hF+`(똨_?IB/pXe bLyHɱFD>{UogUBDU> zN; JVVVVVVVVVVVVVV^_o+IENDB`V$$If!vh5|5#v|#v:V l t65ZytD@D fNormalCJPJ_HaJmH sH tH DA@D Default Paragraph FontRi@R  Table Normal4 l4a (k(No List:U@: f Hyperlink>*B*^JphxC@x fBody Text Indent($ p@ H(#7$8$a$6OJQJ]^JtH lOl fBody Text Indent Char*6CJOJQJ]^J_HaJmH sH tH 4@"4 fHeader  9r 4 @24 fFooter  9r 834RS_`GHTU.}~[ \ w t u   . &{|=>~000000000000000000000000000000000000000000000000000000000000000000@0X00@0X00@0X00@0X00@0 @0 @0 @0@0@0X00x  SSSSSV } =B !XX&KMVX_GoBackCMDNE,NFNGlNH,OIlOJOKOL,PMlPNPOPP,Q YYeuu      dooww  = *urn:schemas-microsoft-com:office:smarttags PlaceName= *urn:schemas-microsoft-com:office:smarttags PlaceTypeB*urn:schemas-microsoft-com:office:smarttagscountry-region9*urn:schemas-microsoft-com:office:smarttagsplace y    y}Yd333 7w;iuf/@W@UnknownGz Times New Roman5Symbol3& z Arial?SimSun"1hl+ t+ aF )aF )!42qHP ?f2Institute of Sport and Physical Activity Research COakleyCOakleyOh+'0 (4 T ` lx4Institute of Sport and Physical Activity Research COakleyNormalCOakley2Microsoft Office Word@Ik@@5aF՜.+,D՜.+,x4 hp  ý) ' 3Institute of Sport and Physical Activity Research Title 8@ _PID_HLINKSA9mailto:angus.duncan@beds.ac.ukH^http://office.microsoft.com/en-us/word-help/test-your-document-s-readability-HP010148506.aspxBM13b:http://www.beds.ac.uk/  !"#$&'()*+,-./012456789:<=>?@ABERoot Entry F~HGData 1Table%*WordDocument.8SummaryInformation(3DocumentSummaryInformation8;CompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q